| 标题 |
[高分] First-in-human, phase 1/2 study of GSK4524101, an oral DNApolymerase theta inhibitor (POLQi), alone or combined with the poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) niraparib in adults with solid tumors
|
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
Nole
Kao
OK
MchemG
LB
Criminology34
Samuel
cnspower
笨笨的元绿
xuxi
sci_fp
lizishu
阮小粒
Rita
youth
dynamoo
无极微光
cdercder
初景
皖公网安备34019202002308
